Your browser is no longer supported. Please, upgrade your browser.
Celcuity Inc.
Index- P/E- EPS (ttm)-0.92 Insider Own32.70% Shs Outstand10.28M Perf Week-0.85%
Market Cap326.96M Forward P/E- EPS next Y-1.97 Insider Trans0.00% Shs Float5.04M Perf Month1.36%
Income-9.50M PEG- EPS next Q-0.20 Inst Own15.80% Short Float11.88% Perf Quarter62.40%
Sales- P/S- EPS this Y-28.20% Inst Trans0.10% Short Ratio1.46 Perf Half Y310.84%
Book/sh1.14 P/B23.61 EPS next Y-93.10% ROA-60.20% Target Price30.00 Perf Year438.20%
Cash/sh- P/C- EPS next 5Y28.00% ROE-64.40% 52W Range4.80 - 30.42 Perf YTD193.78%
Dividend- P/FCF- EPS past 5Y-30.80% ROI- 52W High-11.53% Beta1.51
Dividend %- Quick Ratio10.30 Sales past 5Y- Gross Margin- 52W Low461.21% ATR2.32
Employees30 Current Ratio10.30 Sales Q/Q- Oper. Margin- RSI (14)57.59 Volatility9.05% 8.00%
OptionableNo Debt/Eq0.00 EPS Q/Q-40.60% Profit Margin- Rel Volume0.05 Prev Close25.99
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume409.84K Price26.91
Recom2.00 SMA201.47% SMA5032.65% SMA200127.93% Volume22,209 Change3.54%
Jan-28-21Reiterated H.C. Wainwright Buy $14 → $18
Dec-24-20Reiterated H.C. Wainwright Buy $11 → $14
May-11-20Resumed Craig Hallum Buy
Nov-20-18Initiated H.C. Wainwright Buy $36
May-10-21 04:00PM  
Apr-26-21 05:00PM  
Apr-23-21 09:35AM  
Apr-16-21 03:54PM  
Apr-15-21 08:58AM  
Apr-12-21 04:00PM  
Apr-10-21 05:13AM  
Apr-09-21 04:30PM  
Apr-08-21 04:05PM  
Apr-06-21 02:41AM  
Mar-18-21 08:38AM  
Mar-17-21 07:43AM  
Mar-16-21 04:00PM  
Mar-01-21 03:30PM  
Feb-24-21 02:02PM  
Feb-22-21 08:00AM  
Feb-16-21 04:00PM  
Feb-01-21 01:00PM  
Jan-28-21 08:03AM  
Jan-27-21 05:31PM  
Jan-19-21 02:32PM  
Jan-06-21 01:09AM  
Dec-23-20 07:00AM  
Nov-09-20 04:00PM  
Oct-26-20 03:15PM  
Oct-04-20 09:30AM  
Aug-27-20 09:45AM  
Aug-10-20 04:00PM  
Jul-24-20 04:45PM  
Jul-01-20 05:30PM  
Jun-22-20 07:00PM  
May-07-20 04:00PM  
Apr-23-20 04:40PM  
Apr-07-20 09:23AM  
Mar-12-20 04:00PM  
Feb-27-20 04:15PM  
Dec-12-19 11:07AM  
Dec-11-19 07:25PM  
Dec-05-19 10:24AM  
Nov-07-19 04:01PM  
Nov-01-19 09:00AM  
Oct-28-19 11:28AM  
Oct-24-19 03:31PM  
Sep-24-19 08:50AM  
Sep-11-19 11:37AM  
Sep-10-19 09:01AM  
Sep-09-19 09:37AM  
Aug-19-19 05:55PM  
Aug-08-19 04:00PM  
Jul-25-19 03:34PM  
Jun-27-19 09:00AM  
May-20-19 02:36PM  
May-13-19 09:00AM  
May-07-19 04:01PM  
Apr-29-19 10:50AM  
Apr-23-19 01:48PM  
Apr-12-19 08:50AM  
Apr-10-19 08:45AM  
Apr-04-19 08:33AM  
Mar-07-19 08:58AM  
Mar-05-19 08:48AM  
Feb-26-19 09:20PM  
Feb-14-19 05:12PM  
Dec-25-18 03:00PM  
Dec-11-18 08:10AM  
Dec-07-18 06:33PM  
Nov-13-18 04:00PM  
Oct-31-18 08:00AM  
Oct-30-18 04:56PM  
Oct-19-18 07:45AM  
Oct-16-18 05:51PM  
Aug-09-18 04:00PM  
Aug-02-18 04:31PM  
May-14-18 04:00PM  
May-02-18 12:28PM  
Mar-19-18 07:33AM  
Mar-15-18 04:00PM  
Mar-02-18 04:00PM  
Jan-19-18 07:30AM  
Nov-13-17 07:00AM  
Nov-02-17 01:08PM  
Oct-31-17 09:15PM  
Sep-24-17 09:57AM  
Sep-22-17 04:05PM  
Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.